Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Pharmacokinetics of Staccato® Alprazolam in Healthy Adult Participants: Phase 1, Randomized, Placebo-controlled Ethno-bridging Study

Author:Roebling, Robert   Hayakawa, Yoshinobu   Rospo, Chiara C   Bartmann, Ana Paula   King, Aliceson   Chanteux, Hugues   

Session Name:P9: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Mechanisms, Pharmacokinetics, and Urgent Applications  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P9.007  

Author Institution:UCB Pharma, Monheim am Rhein, Germany  UCB Pharma, Tokyo, Japan  UCB Pharma, Braine l'Alleud, Belgium  UCB Pharma, Smyrna, GA  

Epidemiology and Clinical Characteristics of Meningitis Following COVID-19 Vaccinations: A Systematic Review

Author:Shehata, Mohamed S.A.   Mahfouz, Amany   Ali, Hossam Tharwat   Siddiq, Abdelmonem   Al Mawla, Aya Mustafa   Meshref, Mostafa   

Session Name:P9: Infectious Disease: Neurologic Considerations in COVID-19 1  

Topic:Infectious Disease  

Program Number:P9.009  

Author Institution:Nasr City Insurance Hospital, Faculty of Medicine, Zagazig University, Egypt, Zagazig, Egypt  Faculty of Medicine, Kafrelsheikh University, Egypt, Kafrelsheiks, Egypt  Qena Faculty of Medicine, South Valley University, Egypt, Qena, Egypt  Faculty of Pharmacy, Mansoura University, Egypt, Mansoura, Egypt  Faculty of Medicine, Jordan university of science and technology, Jordan, Ibrid, Jordan  Al-Azhar University, Cairo, Mokkattam City, Egypt  

SURWEY Study of Solriamfetol: Initiation, Titration, Safety, Efficacy, and Follow-up Experience for Patients with OSA in Germany

Author:Winter, Yaroslav   Mayer, Geert   Benes, Heike   Burghaus, Lothar   Abeynayake, Irnesha   Floam, Samantha   Kwak, Hannah   Parks, Gregory   Kallweit, Ulf   

Session Name:P9: Sleep 2  

Topic:Sleep  

Program Number:P9.010  

Author Institution:1. Johannes Gutenberg-University, Mainz Comprehensive Epilepsy and Sleep Medicine Center, Department of Neurology, Mainz, Germany, Mainz, Germany  Philipps-Universität Marburg, Marburg, Germany  5. Somni bene GmbH Institut für Medizinische Forschung und Schlafmedizin Schwerin GmbH, Schwerin, Germany, Heilig Geist-Hospital, Schwerin, Germany  Department of Neurology, Cologne, Germany, Cologne, Germany  Axsome Therapeutics, NYC, NY  Axsome Therapeutics, New York, NY  Axsome Therapeutics (Former), NYC, NY  Axsome Therapeutics, Redwood City, CA  University Witten/Herdecke, Center for Biomedical Education and Researchand Professorship for Narcolepsy and Hypersomnolence Research, Witten, Germany, Bonn, Germany  

Immunoglobulin Level Changes in Patients with Multiple Sclerosis Treated with Anti-CD20 Monoclonal Antibodies

Author:Vollmer, Brandi   Bourassa, Timber   Marsh, Erin   Dao, Vi   Gadkari, Abhijit   Brown, Brandon   Sillau, Stefan   Nair, Kavita   Alvarez, Enrique   

Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2  

Topic:Multiple Sclerosis  

Program Number:P9.011  

Author Institution:University of Colorado, Aurora, CO  Novartis, East Hanover, NJ  

Proposed Mechanism of Action of Soticlestat as an Antiseizure Medication

Author:Murthy, Naga Venkatesha   Asgharnejad, Mahnaz   Benitez, Arturo   Nakashima, Kosuke   Kondo, Shinichi   

Session Name:P9: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Mechanisms, Pharmacokinetics, and Urgent Applications  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P9.013  

Author Institution:Takeda Development Center Americas, Inc., Cambridge, MA  Takeda Pharmaceutical Company Ltd, Fujisawa, Japan